Genstar Capital

News, insights, analysis and data

← Back to Genstar Capital profile

Genstar Capital related stories

All articles and analysis

  • Vestar in $1.1bn oncology chain deal(4)
    Jennifer Harris- 4 January 2013

    Vestar Capital Partners will acquire cancer treatment chain Radiation Therapy Services in a $1.1 billion deal. It is the firm’s first healthcare acquisition since hiring former Bain & Company healthcare pro Anil Shrivastava.

  • Vestar in $1.1bn oncology chain deal(3)
    Jennifer Harris- 4 January 2013

    Vestar Capital Partners will acquire cancer treatment chain Radiation Therapy Services in a $1.1 billion deal. It is the firm’s first healthcare acquisition since hiring former Bain & Company healthcare pro Anil Shrivastava.

  • Vestar in $1.1bn oncology chain deal(2)
    Jennifer Harris- 4 January 2013

    Vestar Capital Partners will acquire cancer treatment chain Radiation Therapy Services in a $1.1 billion deal. It is the firm’s first healthcare acquisition since hiring former Bain & Company healthcare pro Anil Shrivastava.

  • Vestar in $1.1bn oncology chain deal
    Jennifer Harris- 4 January 2013

    Vestar Capital Partners will acquire cancer treatment chain Radiation Therapy Services in a $1.1 billion deal. It is the firm’s first healthcare acquisition since hiring former Bain & Company healthcare pro Anil Shrivastava.

  • Genstar nabs Canadian entrepreneur for advisory board(3)
    Jennifer Harris- 4 January 2013

    Genstar Capital has added entrepreneur Kevin O’Leary to its Strategic Advisory Board. O’Leary will help the firm strengthen its Canadian portfolio.

  • Genstar nabs Canadian entrepreneur for advisory board(2)
    Jennifer Harris- 4 January 2013

    Genstar Capital has added entrepreneur Kevin O’Leary to its Strategic Advisory Board. O’Leary will help the firm strengthen its Canadian portfolio.

  • Genstar in $790m research lab deal(3)
    Jennifer Harris- 4 January 2013

    San Francisco-based Genstar Capital will acquire clinical research organization PRA International in $790 million deal – the largest the firm has announced to date.

  • Genstar in $790m research lab deal(2)
    Jennifer Harris- 4 January 2013

    San Francisco-based Genstar Capital will acquire clinical research organization PRA International in $790 million deal – the largest the firm has announced to date.

  • Genstar in $790m research lab deal
    Jennifer Harris- 4 January 2013

    San Francisco-based Genstar Capital will acquire clinical research organization PRA International in $790 million deal – the largest the firm has announced to date.

  • Genstar nabs Canadian entrepreneur for advisory board
    Jennifer Harris- 4 January 2013

    Genstar Capital has added entrepreneur Kevin O’Leary to its Strategic Advisory Board. O’Leary will help the firm strengthen its Canadian portfolio.